What is ALX Oncology Holdings Inc. (ALXO)?
ALX Oncology Holdings Inc. (ALXO) is a stock traded on the Cboe One exchange, denominated in USD. It is a clinical-stage biotechnology company focused on developing immuno-oncology therapies that target cancer's ability to evade the immune system. As a publicly listed equity, its shares can be bought and sold by investors seeking exposure to the biopharmaceutical sector. TradeSearcher has run over 2,100 backtests on ALXO, drawing on price data going back to 2020 to evaluate a wide range of trading strategies across multiple timeframes.